Persist AI

Persist assist pharmaceutical companies in developing long-acting formulations 50% faster. Because the formulation development process is manual and relies on scientific intuition, it takes a pharmaceutical company 5-10 years to develop a long acting formulation for a drug. This effort is divided into five years of pre-clinical development and five years of clinical testing. Their goal is to use machine learning and automation to reduce the time required for pre-clinical formulation development to three months, making the formulation development process 50% faster.

Persist AI headquartered in United States, North America, operates in the Biotechnology, Artificial Intelligence (AI), Machine Learning sector. The company focuses on Biotechnology and has secured $108.0M in funding across 24 round(s). With a team of 11-50 employees, Persist AI is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - Persist AI, raised $4.0M. Discover more about their projects, partnerships, and impact on our platform.